Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)

Summary

The purpose of this study is to determine the safety and efficacy of Thermodox, a thermally sensitive liposomal doxorubicin, in combination with thermal ablation in the treatment of hepatic colorectal liver metastases (CRLM).

Timeline

Start

2011-09

Primary completion

2013-05

Completion

2013-06

Outcome

Outcome not reported

Stopped: “trial design contingent on RFA optimization”

Drugs

Indications